Related Experiment Video
Updated: Jun 23, 2026
09:31
Touchscreen Sustained Attention Task (SAT) for Rats
Published on: September 15, 2017
Individual variation in a cholinergic receptor gene modulates attention
Ivar Reinvang1, Astri J Lundervold, Helge Rootwelt
1Center for Study of Human Cognition, Department of Psychology, University of Oslo, Norway. ivar.reinvang@psykologi.uio.no
Neuroscience Letters
|May 12, 2009
Summary
Genetic variations in the CHRNA4 gene impact attention and processing speed, particularly in older adults. This study found no parallel effects on memory function, suggesting receptor efficiency is key for attention.
Area of Science:
- Neuroscience
- Genetics
- Cognitive Psychology
Background:
- Cholinergic systems significantly influence attention.
- Genetic variations in alpha4beta2 nicotinic receptors are linked to attentional network function.
- A specific CHRNA4 gene polymorphism (rs1044396) affects visual and auditory attention.
Purpose of the Study:
- To investigate the impact of CHRNA4 gene variation on neuropsychological measures of memory and attention.
- To examine age-related effects on attention and memory performance based on genetic variation.
- To understand the relationship between nicotinic receptor efficiency and cognitive functions.
Main Methods:
- Studied a sample of 488 adults across a lifespan.
- Utilized neuropsychological tests to assess attention and memory.
- Analyzed performance differences based on CHRNA4 gene (rs1044396) genotypes (TT, TC, CC).
Main Results:
- TT homozygotes exhibited slower performance on speed and attention tasks compared to TC or CC carriers.
- The effect of genotype on attention was more pronounced in older adults (70-79 years) on complex attention tasks.
- No significant association was found between the CHRNA4 polymorphism and memory performance.
Conclusions:
- CHRNA4 gene variation influences attention and processing speed, with age-dependent effects.
- Reduced nicotinic receptor efficiency appears to affect attention and speed, but not memory.
- Findings suggest both normal aging and early pathological changes in receptor function may contribute to observed cognitive differences.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:32Position-effect Variegation
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...